A new clinical trial found that pulsed-field catheter ablation using Boston Scientific's Farapulse system was more effective than medication in treating persistent atrial fibrillation. One year after ...

Johnson & Johnson has initiated the PERSIGMA randomized controlled trial (RCT), one of the first randomized studies ...

Atrial fibrillation (AF) in older adults extends well beyond stroke prevention. Advancing age is the strongest demographic driver of AF prevalence and ...

Research links artificially-sweetened and sugar-sweetened drinks to a higher risk of atrial fibrillation. Atrial fibrillation is associated with a higher risk of stroke and heart attack. It’s not ...

COMPASS presents a “scalable framework” for other centers that want to improve AF care, but additional efforts are needed.

Clinical Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

Researchers are urging a shift toward atrial fibrillation (AF) care models that account for both age and frailty, factors often overlooked in current practice. Frailty affects treatment choices for ...

In randomized trials in patients with atrial fibrillation (AF), treatment strategies that restore and maintain sinus rhythm (rhythm control) have not shown convincing advantages over those that simply ...

Atrial fibrillation is the most common cardiac arrhythmia worldwide and prevalence is expected to continue rising at an exponential rate with an aging population and increasing rates of obesity and ...

Atrial fibrillation diagnosed before age 70 years is associated with a 21% increased risk of developing dementia and a 36% higher risk for early-onset forms of the condition, according to the results ...